Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sander R van Hooff
Affiliation
Princess Maxima Center for Pediatric Oncology
ORCID
Career Start Year
2008
Papers
38
H Index
22
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37020198
The potential of PARP as a therapeutic target across pediatric solid malignancies.
BMC Cancer
2023
37528411
Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes.
Genome Biol
2023
37540673
Two opposing gene expression patterns within ATRX aberrant neuroblastoma.
PLoS One
2023
34963094
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.
Eur J Cancer
2022
36182817
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Eur J Cancer
2022
36237330
Chromosome 11q loss and <i>MYCN</i> amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma.
Front Oncol
2022
34117376
BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer.
Cell Death Differ
2021
33547074
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.
Sci Adv
2021
33673003
AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.
Cancers (Basel)
2021
34408135
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery.
Nat Commun
2021
34433038
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors.
Cell Rep
2021
34575700
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression.
J Pers Med
2021
31526760
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
Cancer Cell
2019
30151914
Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Int J Cancer
2019
29305587
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.
Cell Death Differ
2018
28692036
Neoadjuvant chemotherapy affects molecular classification of colorectal tumors.
Oncogenesis
2017
28368388
Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer.
Oncogenesis
2017
26733613
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
Clin Cancer Res
2016
27221051
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.
EMBO Mol Med
2016
27157610
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
Oncogene
2016
26797113
An endometrial gene expression signature accurately predicts recurrent implantation failure after IVF.
Sci Rep
2016
24764155
Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Head Neck
2015
26700642
A high-resolution gene expression atlas of epistasis between gene-specific transcription factors exposes potential mechanisms for genetic interactions.
BMC Biol
2015
26160848
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).
Oncotarget
2015
26022646
The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma.
Pathobiology
2015
24766815
Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressors.
Cell
2014
23441134
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.
Neoplasia
2013
24002600
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.
Br J Cancer
2013
21976730
Tight cooperation between Mot1p and NC2β in regulating genome-wide transcription, repression of transcription following heat shock induction and genetic interaction with SAGA.
Nucleic Acids Res
2012
23185333
Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastases.
PLoS One
2012
23182196
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma.
Lancet Oncol
2012
23028359
Two distinct repressive mechanisms for histone 3 lysine 4 methylation through promoting 3'-end antisense transcription.
PLoS Genet
2012
23045589
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.
J Clin Oncol
2012
21596317
The specificity and topology of chromatin interaction pathways in yeast.
Mol Cell
2011
21145464
Functional overlap and regulatory links shape genetic interactions between signaling pathways.
Cell
2010
19320556
The construction of genome-based transcriptional units.
OMICS
2009
19401678
Adaptable gene-specific dye bias correction for two-channel DNA microarrays.
Mol Syst Biol
2009
18689827
Organization and integration of biomedical knowledge with concept maps for key peroxisomal pathways.
Bioinformatics
2008
1 - 38 of 38
Column Actions
Search
Recommended Authors
Huwate Yeerna
Moores Cancer Center, University of California
Career Start Year
2015
Number of shared co-authors
0
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year
2013
Number of shared co-authors
0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year
2010
Number of shared co-authors
0
Darragh G McArt
Queen's University Belfast
Career Start Year
2009
Number of shared co-authors
0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year
2007
Number of shared co-authors
2
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2006
Number of shared co-authors
6
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year
2005
Number of shared co-authors
1
Joshy George
Peter MacCallum Cancer Centre
Career Start Year
2005
Number of shared co-authors
0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year
2003
Number of shared co-authors
4
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
6
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year
2003
Number of shared co-authors
1
Obi L Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year
2002
Number of shared co-authors
0
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
1
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
3
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year
2001
Number of shared co-authors
1
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year
2000
Number of shared co-authors
2
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year
2000
Number of shared co-authors
15
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
0
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year
1998
Number of shared co-authors
4
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year
1997
Number of shared co-authors
6
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1996
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
2
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year
1989
Number of shared co-authors
4
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year
1988
Number of shared co-authors
4
Pablo Tamayo
University of California San Diego
Career Start Year
1988
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Frank C P Holstege
Princess Maxima Center for Pediatric Oncology
Co-authored papers
15
Jan Paul Medema
Oncode Institute
Co-authored papers
11
Jan J Molenaar
Co-authored papers
9
Dik van Leenen
Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University
Co-authored papers
8
Marian J A Groot Koerkamp
Princess Maxima Center for Pediatric Oncology Research
Co-authored papers
7
Thanasis Margaritis
Princess Maxima Center for Pediatric Oncology
Co-authored papers
6
Patrick Kemmeren
Princess Maxima Center for Pediatric Oncology
Co-authored papers
6
Philip Lijnzaad
Princess Maxima Center for Pediatric Oncology
Co-authored papers
6
Mariel O Brok
Princess Maxima Center for Pediatric Oncology
Co-authored papers
5
Jan Koster
Amsterdam University Medical Centers location AMC
Co-authored papers
5
Louis Vermeulen
Oncode Institute
Co-authored papers
5
Joris J Benschop
Center for Molecular Medicine, University Medical Center Utrecht
Co-authored papers
5
Nathalie Brabers
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers
5
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
4
Tineke L Lenstra
the Netherlands Cancer Institute, Oncode Institute
Co-authored papers
4
Katrin Sameith
Center for Molecular and Cellular Bioengineering
Co-authored papers
4
Cheuk W Ko
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers
4
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
3
Sake van Wageningen
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers
3
Berend Snel
Utrecht University
Co-authored papers
3
Loes A L van de Pasch
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers
3
Eva Apweiler
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers
3
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
3
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers
2
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Antony J Miles
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers
2
Linda V Bakker
Wageningen University and Research
Co-authored papers
2
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Co-authored papers
2
Dorothea Fiedler
Leibniz Forschungsinstitut fur Molekulare Pharmakologie (FMP)
Co-authored papers
1
Connie R Jimenez
Co-authored papers
1
1 - 30